These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 25195308)
21. A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients. Ball D; Bishop J; Smith J; Crennan E; O'Brien P; Davis S; Ryan G; Joseph D; Walker Q Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):267-72. PubMed ID: 7836079 [TBL] [Abstract][Full Text] [Related]
22. Tumor lysis syndrome in small cell lung cancer: a case report and review of the literature. Jallad B; Hamdi T; Latta S; Alhosaini MN; Kheir F; Iroegbu N Onkologie; 2011; 34(3):129-31. PubMed ID: 21358219 [No Abstract] [Full Text] [Related]
23. [Chemically-induced paraneoplastic hyperleukocytic lung]. Le Guen Y; Lebeau B Rev Mal Respir; 1999 Dec; 16(6):1139-41. PubMed ID: 10637912 [TBL] [Abstract][Full Text] [Related]
24. Tumor lysis syndrome after bortezomib therapy for plasma cell leukemia. Jaskiewicz AD; Herrington JD; Wong L Pharmacotherapy; 2005 Dec; 25(12):1820-5. PubMed ID: 16305302 [TBL] [Abstract][Full Text] [Related]
25. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials. Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861 [TBL] [Abstract][Full Text] [Related]
26. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma. Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088 [TBL] [Abstract][Full Text] [Related]
27. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature. Taira F; Horimoto Y; Saito M Breast Cancer; 2015 Nov; 22(6):664-8. PubMed ID: 23420376 [TBL] [Abstract][Full Text] [Related]
28. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer]. Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022 [TBL] [Abstract][Full Text] [Related]
29. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer]. Li DX; Chen XB Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023 [TBL] [Abstract][Full Text] [Related]
30. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer. Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478 [TBL] [Abstract][Full Text] [Related]
31. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Kalemkerian GP; Darwish B; Varterasian ML Am J Med; 1997 Nov; 103(5):363-7. PubMed ID: 9375703 [TBL] [Abstract][Full Text] [Related]
32. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer. Miller AA; Al Omari A; Murry DJ; Case D Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403 [TBL] [Abstract][Full Text] [Related]
33. Fatal tumor lysis syndrome and gastric hemorrhage associated with metastatic small-cell lung carcinoma. Marinella MA Med Pediatr Oncol; 1999 Jun; 32(6):464-5. PubMed ID: 10358713 [No Abstract] [Full Text] [Related]
34. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies. Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098 [TBL] [Abstract][Full Text] [Related]
36. Hypersensitivity and tumor lysis syndrome associated with cetuximab treatment: should we be afraid? Cihan S; Atasoy A; Yildirim Y; Babacan NA; Kos TF Tumori; 2015 Apr; 101(2):e40-5. PubMed ID: 25721679 [TBL] [Abstract][Full Text] [Related]
37. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. Drakos P; Bar-Ziv J; Catane R Am J Clin Oncol; 1994 Dec; 17(6):502-5. PubMed ID: 7977169 [TBL] [Abstract][Full Text] [Related]
38. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy. Hainsworth JD; Greco FA Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970 [TBL] [Abstract][Full Text] [Related]
39. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer. Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659 [TBL] [Abstract][Full Text] [Related]
40. Carfilzomib-induced tumor lysis syndrome in relapsed multiple myeloma: a report of two cases. Terzi Demirsoy E; Birtas Atesoglu E; Eren N; Gedük A; Mehtap O; Tarkun P; Hacıhanefioğlu A Tumori; 2019 Dec; 105(6):NP24-NP27. PubMed ID: 30580656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]